You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-HSV1 + HSV2 gD antibody [2C10] (ab6507)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-HSV1 + HSV2 gD antibody [2C10]
See all HSV1 + HSV2 gD products (6) ...

Description

Mouse monoclonal [2C10] to HSV1 + HSV2 gD

Tested applications

ICC, WB, ELISAmore details

Immunogen

Herpes Virus

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

Storage buffer

Phosphate buffered saline

Concentration

Concentration information loading...

Purity

Protein A purified

Clonality

Monoclonal

Clone number

2C10

Myeloma

NS1/1-Ag4-1

Isotype

IgG2a

Light chain type

kappa

  • Western blot - HSV1 + HSV2 gD antibody [2C10] (ab6507)Western blot - HSV1 + HSV2 gD antibody [2C10] (ab6507) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab6507 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application notes

ELISA: 1/102,400 (see reference for Sandwich ELISA).
ICC(IF): 1/3,200 (HSV-2) - 1/25,600 (HSV-1).
WB: 1/10,000.

Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

Target

Relevance

Herpes simplex virus 1 and 2 (HSV-1 and HSV-2) are two species of the herpes virus family, Herpesviridae, which cause infections in humans. They are also called Human Herpes Virus 1 and 2 (HHV-1 and HHV-2) and are neurotropic and neuroinvasive viruses; they enter and hide in the human nervous system, accounting for their durability in the human body. Under a microscope, HSV- 1 and 2 are virtually identical, sharing approximately 50% of their DNA. Both types infect the body's mucosal surfaces, usually the mouth or genitals, and then establish latency in the nervous system. HSV-1 is commonly associated with herpes outbreaks of the face known as cold sores or fever blisters, whereas HSV-2 is more often associated with genital herpes. Herpes simplex viruses (HSV) use multiple and sequential receptors to enter host cells. HSV glycoprotein D (gD) has been implicated in binding to cellular receptors that facilitate virus penetration into cells. Herpes simplex virus type 1 (HSV-1) glycoprotein D (gD) is an essential component of the entry apparatus that is responsible for viral penetration and subsequent cell-cell spread.

Alternative names

  • Envelope glycoprotein D antibody
  • GD antibody
  • Glycoprotein D antibody
  • US6 antibody

Anti-HSV1 + HSV2 gD antibody [2C10] images:

  Western blot - HSV1 + HSV2 gD antibody [2C10] (ab6507)

Western blot - HSV1 + HSV2 gD antibody [2C10] (ab6507)



Observed band size : 55 kDa (why is the actual band size different from the predicted?)


The WB was completed using the HSV-1 Antigen and the HSV-2 Infected Cell Extract at 10 µg/cm

References for Anti-HSV1 + HSV2 gD antibody [2C10] (ab6507)

This product has been referenced in:

  • Del Campo Jet al. Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in mice. Vaccine 28:1193-200 (2010). WB.Read more (PubMed: 19945418) »
  • Reszka NJet al. Construction and properties of a herpes simplex virus 2 dl5-29 vaccine candidate strain encoding an HSV-1 virion host shutoff protein. Vaccine 28:2754-62 (2010). WB.Read more (PubMed: 20117270) »

See all 4 publications for this product

Publishing research using ab6507? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"